Targeting tumor necrosis factor α in psoriasis and psoriatic arthritis

By Fantuzzi Francesca   Del Giglio Micol   Gisondi Paolo   Girolomoni Giampiero  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 9, 2008-09 ,pp. : 1085-1096

Informa Healthcare

Access to resources Recommend Favorite

Tumor Necrosis Factor Inhibitors as Therapeutic Choice in Psoriasis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 1, 2009-03 ,pp. : 47-50

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α Inhibitors

By  

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 12, 2018-03 ,pp. : 945-963

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Selectin Functions in the Therapy of Psoriasis

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 2, 2004-06 ,pp. : 163-168

Bentham Science Publishers

Access to resources Recommend Favorite

A Threshold Hazard Model for Estimating Serious Infection Risk Following Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Patients

By Fu Bo   Lunt Mark   Galloway James   Dixon Will   Hyrich Kimme   Symmons Deborah  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 2, 2013-03 ,pp. : 461-476

Taylor & Francis Ltd

Access to resources Recommend Favorite